Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
1.4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
3.1 Europe Aneuploidy Market by Country
3.2 Europe Chromosomal Abnormalities Market by Country
3.3 Europe X-linked diseases Market by Country
3.4 Europe Single Gene Disorders Market by Country
3.5 Europe HLA Typing Market by Country
3.6 Europe Gender selection Market by Country
3.7 Europe Other Test Type Market by Country
Chapter 4. Europe Preimplantation Genetics Diagnosis (PGD) Market by Country
4.1 Germany Preimplantation Genetics Diagnosis (PGD) Market
4.1.1 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2 UK Preimplantation Genetics Diagnosis (PGD) Market
4.2.1 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3 France Preimplantation Genetics Diagnosis (PGD) Market
4.3.1 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4 Russia Preimplantation Genetics Diagnosis (PGD) Market
4.4.1 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.5 Spain Preimplantation Genetics Diagnosis (PGD) Market
4.5.1 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.6 Italy Preimplantation Genetics Diagnosis (PGD) Market
4.6.1 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.7 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market
4.7.1 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
Chapter 5. Company Profiles
5.1 Illumina, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.2 Invitae Corporation
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expenses
5.3 Natera Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expenses
5.4 Agilent Technologies, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent Strategies and Developments:
5.4.5.1 Approvals and Trials:
5.5 PerkinElmer, Inc.
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expense
5.5.5 Recent Strategies and Developments:
5.5.5.1 Product Launches and Product Expansions:
5.6 Quest Diagnostics Incorporated
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental Analysis
5.7 Reproductive Genetic Innovations
5.7.1 Company Overview
5.8 PacGenomics
5.8.1 Company Overview
5.9 CeGaT GmbH
5.9.1 Company Overview
5.10. Laboratory Corporation of America Holdings
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
Unique Offerings 
